Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
First patient in New York has been cured of sickle cell anemia with advanced treatment
Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...
'Common disease took my sight and ate my body - it takes 130 people to keep me alive'
Amid a genetic breakthrough in the treatment of sickle cell disease, The Mirror investigates the agonising reality of living with the condition that leave sufferers in unbearable pain ...
HealthDay on MSN1d
First Patient Cured of Sickle Cell Anemia
For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic ...
European Medical Journal10d
Universal Genetic Testing Proposed for Haemoglobinopathy Newborn Screening
Explore the benefits of adopting universal molecular genetic testing for newborn screening of haemoglobinopathies to improve ...
Sickle cell gene therapy frees teen from life of pain
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
The Punch on MSN2d
Gene therapy delivers alternative sickle cell cure in US
Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...
News-Medical.Net on MSN6d
CRISPR technologies paving the way for advances in regenerative medicine
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...
The Punch on MSN11d
The role of antioxidants in sickle cell management
One of the major contributors to complications in SCD is oxidative stress, a condition where the body’s antioxidant defense ...
MedPage Today on MSN5d
Approved Sickle Cell Drug Fails to Beat Placebo in Trial
Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
‘I’m Unstoppable’: New gene therapy cures first New Yorker of sickle cell anemia
Twenty-one-year-old Sebastien Beauzile was all smiles as he was serenaded with “Happy Birthday” on what he calls his new birthday at Cohen Children’s Medical ...
The Oxford Student13d
CASGEVY: NHS Approves First Sickle Cell Gene Therapy
Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic ...